The global drug screening market in terms of revenue was estimated to be worth $5.3 billion in 2021 and is poised to reach $11.6 billion by 2026, growing at a CAGR of 16.8% from 2021 to 2026. The ...
The global cancer biomarkers market in terms of revenue was estimated to be worth $12.4 billion in 2021 and is poised to reach $28.2 billion by 2026, growing at a CAGR of 17.7% from 2022 to 2027. ...
The global platelet aggregation devices market is poised to reach a value of 342.4 Million by 2020, growing at a CAGR of 21.0% from 2015 to 2020. Factors such as rising incidences of target disea ...
The global liquid biopsy market in terms of revenue was estimated to be worth $4.3 billion in 2022 and is poised to reach $10.0 billion by 2027, growing at a CAGR of 18.3% from 2022 to 2027. The ...
The global breast cancer liquid biopsy market is projected to grow at a CAGR of 23.1%. Factors such as increasing prevalence of breast cancer, increasing preference for noninvasive procedures, in ...
The Carrier Screening Market is projected to reach USD 4.0 billion by 2024, at a CAGR of 17.5% during the forecast period. The major companies in the global carrier screening industry include Ill ...
The global point of care diagnostics market in terms of revenue was estimated to be worth $49.7 billion in 2023 and is poised to reach $77.8 billion by 2028, growing at a CAGR of 9.4% from 2023 t ...
The global biomarkers market in terms of revenue was estimated to be worth $59.1 billion in 2023 and is poised to reach $104.0 billion in 2028, growing at a CAGR of 12.0% from 2023 to 2028. The n ...
The global in vitro diagnostics market in terms of revenue was estimated to be worth $117.8 billion in 2022 and is poised to reach $138.4 billion by 2027, growing at a CAGR of 3.3% from 2022 to 2 ...
The global market for clinical laboratory services is projected to grow at a CAGR of 5.2%. The major players in the market are Mayo Medical Laboratories (US), Laboratory Corporation of America Ho ...
The global biomarker technologies market is projected to grow at a CAGR of 9.7%. The key players in the biomarker technologies market are Thermo Fisher Scientific (US), Agilent Technologies (US), ...
The COVID 19 Impact on IVD (In Vitro Diagnostics) Market is expected to grow from USD 61.7 billion in 2020 to USD 77.9 billion by 2025, at a CAGR of 4.8% during the forecast period. As of 2019, s ...
Latent demand for you, for your prospective client, or your prospective partners